Biographical Sketch
Marie M. Budev DO, MPH, FCCP, is the Assistant Medical Director of one of the largest lung transplant and heart-lung transplant programs in the country. In addition to her transplant responsibilities she is actively involved in the internal medicine residency program as an Associate Program Director. Her treatment interests include all forms of end-stage lung disease including but not limited to cystic fibrosis, ILD/UIP, COPD and pulmonary hypertension.
Specialty Interests
Cystic Fibrosis, gender specific pulmonary issues, lung and heart lung transplantation, secondary pulmonary hypertension
Awards & Honors
Fellow College of Chest Physicians - FCCP
Received private research funding
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 9/4/2008, Dr.
Budev has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Budev receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
Boehringer Ingelheim Pharmaceuticals, Inc.
Eisai Medical Research Inc.
Pfizer Inc.
